FERTIN PHARMA A/S — Credit Rating and Financial Key Figures

FERTIN PHARMA A/S (CVR number: 25834844) is a company from VEJLE. The company reported a net sales of 1104.2 mDKK in 2024, demonstrating a growth of 9 % compared to the previous year. The operating profit percentage was poor at -15 % (EBIT: -166 mDKK), while net earnings were -259 mDKK. The profitability of the company measured by Return on Assets (ROA) was -9.2 %, which can be considered poor and Return on Equity (ROE) was -26.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 58.5 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. FERTIN PHARMA A/S's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.